Supernus Pharmaceuticals (SUPN) Q4 2024 Earnings

Nov 4Confirmed
Q1 2024
Q2 2024
Q3 2024
Q4 2024
0
0.39
0.78
1.17

Details

Expected EPS
0.443333
Actual EPS
1.168432
Surprise EPS
0.73
Surprise Percent
+163.56%

Description

⁨Supernus Pharmaceuticals⁩ (⁦SUPN⁩) has reported earnings of ⁦1.168432⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts